Humana, Inc., (NYSE: HUM) has tapped Dr. Sanjay Shetty to become president of its health care services business, CenterWell. Shetty’s appointment continues a reorganization that the insurance giant undertook last year that arranged its business into two segments, insurance and CenterWell. The latter contains the former home health assets of Kindred at Home, of which […]
Through acquisitions and contracts with providers, more payers are going all-in on home-based care. The quest for cost reductions, often through risk-based models, is leading a rising number of insurance companies and other payers to make (sometimes) huge investments in the space. Among them is UnitedHealth Care (NYSE: UNH). These investments underscore the rising profile […]
Though buyers remain hungry for hospice acquisitions, smaller deals will likely be the most prevalent during 2023. Acquisition patterns established in 2021 and 2022 are shaping the M&A outlook for the current year. The number of hospice and home health deals fell by nearly a third last year, though a few “megadeals” have driven up […]
In 2022, the hospice community laid the groundwork for a transformational 2023. This year saw industry-changing acquisitions, some of the worst labor headwinds to date, the return of sequestration and a sometimes volatile national economy. During late 2021 and 2022, the U.S. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice […]
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]
As the dust settles from its divestiture of Kindred at Home’s hospice and personal care segments, Humana Inc. (NYSE: HUM) seeks to further expand into value-based care as both a provider and a payer. Humana in August completed its $2.8 billion sale of a 60% stake in Kindred at Home’s hospice and personal care businesses […]
A recent federal court decision that cleared the way for UnitedHealth Group’s (NYSE: UNH) forthcoming purchase of Change Healthcare (NASDAQ: CHNG) is a positive sign for the insurance company’s pending acquisition of LHC Group (NASDAQ: LHCG). The U.S. Department of Justice sought to block the $13 billion Change Healthcare transaction on anti-trust grounds, alleging that […]
Humana Inc. (NYSE: HUM) has completed its $2.8 billion sale of Kindred at Home’s hospice and personal care segments, divesting a 60% stake to the private equity firm Clayton, Dubilier & Rice. Humana will retain the remaining 40%. The sale coincides with Humana’s stated goal of raising its enterprise value by $1 billion, while building […]
Humana Inc. (NYSE: HUM) expects revenue to fall by $400 million immediately following its divestiture of the Kindred at Home hospice segment, but anticipates this to be offset by lower operating costs and, in time, the proceeds of the sale. The company signed a definitive agreement in April to sell a 60% stake in Kindred […]
Two Oregon locations included in Humana’s (NYSE: HUM) divestiture of Kindred at Home’s hospice assets are currently under review by the state’s health authority — part of the diligence process involved in any M&A transaction. Humana in April signed a definitive agreement to sell a 60% stake in Kindred at Home to private equity firm […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
